Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 USD | -.--% | +8.58% | -0.10% |
Business Summary
Number of employees: 55
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 21 | 100.0 % | 18 | 100.0 % | -10.77% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 21 | 100.0 % | 18 | 100.0 % | -10.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Sekulich
PSD | President | 59 | 19-04-30 |
Willis Lee
CHM | Chairman | 64 | 19-07-16 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 11-04-30 |
Mark Diamond
CIO | Chief Investment Officer | - | - |
Charles Stark
CTO | Chief Tech/Sci/R&D Officer | 68 | 12-12-31 |
Lan T. Tran
ADM | Chief Administrative Officer | 48 | 19-07-16 |
Dale E. Short
SEC | Corporate Secretary | - | 18-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 19-07-16 |
Willis Lee
CHM | Chairman | 64 | 19-07-16 |
Ian Zwicker
BRD | Director/Board Member | 77 | 19-07-16 |
George Sekulich
PSD | President | 59 | 19-04-30 |
Seah LIm
BRD | Director/Board Member | 66 | 22-10-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,637,554 | 25,870,168 ( 48.23 %) | 0 | 48.23 % |
Company contact information
Emmaus Life Sciences, Inc.
21250 Hawthorne Boulevard Suite 800
90503, Torrance
+
http://www.emmausmedical.comSector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.10% | 6.18M | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- EMMA Stock
- Company Emmaus Life Sciences, Inc.